Vaccine potency wanes, but third COVID shot restores 95 percent efficacy, new data show
By
Alicia Lasek
Sep 16, 2021
New data from vaccine maker Pfizer and Israel’s health ministry may help U.S. health agencies make a case for recommending COVID-19 booster shots, various sources report.
Feds race to buy COVID antibody cocktails
By
Alicia Lasek
Oct 14, 2020
The federal government is planning to stockpile COVID-19 antibody drugs in an effort to ensure treatment availability while the country awaits a vaccine.
FDA greenlights Novavax’s COVID-19 vaccine, adding unique option to U.S. arsenal
By
Alicia Lasek (f3)
Jul 14, 2022
The FDA late Wednesday authorized Novavax’s adjuvanted COVID-19 vaccine for emergency use in adults aged 18 years and older.
LeadingAge’s president and CEO has asked Congress to ensure access to COVID-19 tests, vaccines and treatments in letters supporting the White House’s request for COVID-19 supplemental funds.
Parkinson: Vaccinate all long-term care by March and slash coronavirus mortality 40 percent
By
Alicia Lasek
Dec 08, 2020
A one-month delay “could result in more than 20,000 of our residents losing their lives when a vaccine could have saved them,” AHCA / NCAL leader Mark Parkinson said Monday.
Omicron renders Pfizer vaccine less effective; variant surge to hit U.S. by January
By
Alicia Lasek
Dec 15, 2021
The vaccine is less able to prevent infection, but retains 70% protection against hospitalization, a new study shows. The news comes as federal health officials warn that omicron is spreading rapidly in...